Digestive Endoscopy Unit, University Campus Bio-Medico, Rome, Italy.
Digestive Endoscopy Unit, University Campus Bio-Medico, Rome, Italy.
Dig Liver Dis. 2017 Sep;49(9):1009-1013. doi: 10.1016/j.dld.2017.04.015. Epub 2017 May 2.
Endoscopic full-thickness resection (EFTR) provides complete en-bloc resection with a histopathological evaluation of submucosal, muscular, and serosal layers. The aim of this study was to investigate the efficacy and safety of a novel over-the-scope device for colorectal EFTR.
In this retrospective, observational, open-label case study, a total of 20 patients with superficial colorectal neoplasms, underwent EFTR using a new endoscopic full-thickness resection device (FTRD; Ovesco Endoscopy, Tübingen, Germany). Endoscopic treatment outcomes (technical success, rate of EFTR, adverse events) and early follow-up at three months, were analyzed.
We reported a 100% of technical success, defined as full-thickness resection. Among the R1 resections, histology was negative for neoplasm. Non-lifting adenomas had histology positive for adenocarcinoma: seven T1/G1/sm1; one T1/G1/sm2; one, who underwent a surgical resection, T1/G1/sm3. Mean size of the resected lesions was 26mm, ranging from 10 to 42mm. One (5%) patient developed abdominal pain, fever and leukocytosis and was treated conservatively with medical therapy. In all specimens, histological complete resection was confirmed.
EFTR is a feasible and effective technique that could become a valid alternative to EMR and ESD in the management of recurrent adenomas, no-lifting lesions and scars of R1 resections. However, prospective studies are needed to further evaluate the device and technique.
内镜全层切除术 (EFTR) 可提供完整的整块切除,并对黏膜下、肌肉层和浆膜层进行组织病理学评估。本研究旨在探讨一种新型内镜全层切除装置在结直肠 EFTR 中的疗效和安全性。
在这项回顾性、观察性、开放标签的病例研究中,共有 20 名患有浅表性结直肠肿瘤的患者接受了一种新型内镜全层切除装置(FTRD;Ovesco Endoscopy,图宾根,德国)的 EFTR 治疗。分析了内镜治疗结果(技术成功率、EFTR 率、不良事件)和三个月时的早期随访情况。
我们报告了 100%的技术成功率,定义为全层切除。在 R1 切除中,组织学检查结果为肿瘤阴性。非提升性腺瘤的组织学检查结果为腺癌:七例 T1/G1/sm1;一例 T1/G1/sm2;一例接受手术切除的患者,T1/G1/sm3。切除病变的平均大小为 26mm,范围为 10-42mm。一例(5%)患者出现腹痛、发热和白细胞增多,经保守治疗(药物治疗)治愈。所有标本均证实组织学完全切除。
EFTR 是一种可行且有效的技术,可能成为 EMR 和 ESD 治疗复发性腺瘤、非提升病变和 R1 切除疤痕的有效替代方法。然而,需要前瞻性研究进一步评估该设备和技术。